Novartis misses quarterly sales, profit estimates as Entresto generics hit growth
April 28 (Reuters) – Swiss drugmaker Novartis reported first-quarter core operating profit and sales below market expectations on…
Roche’s 2025 profit blunted by weakened US dollar
Roche’s adjusted operating profit rose by a lower-than-expected 5% in 2025, due to the weakened US dollar, despite…
Roche’s 2025 profit blunted by weakened US dollar
Roche’s adjusted operating profit rose by a lower-than-expected 5% in 2025, due to the weakened US dollar, despite…
Strong Sales Growth and Strategic …
Group Sales Growth: 7% overall; 9% excluding COVID-19 impact. Core Operating Profit Growth: 14% increase. Core Operating Margin:…
Basilea Pharmaceutica Ltd (BPMUF) Full Year 2025 Earnings Call Highlights: Strong Revenue …
This article first appeared on GuruFocus. Total Revenue: CHF232.4 million, up 11.4% year-on-year. Cresemba Global In-Market Sales: USD693…
Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance
Basilea Pharmaceutica International Ltd, Allschwil 15% royalty income increase 11% total revenue increase Tripled net cash position Phase…
Zurich Insurance posts higher operating profit, does not expect tariff hit
By Paolo Laudani (Reuters) -Zurich Insurance reported a 6% rise in its first-half operating profit on Thursday as…